Safety

ImmunityBio Faces Lawsuit Over Cancer Vaccine Claims

By Daybreak Brief Editorial Team

ImmunityBio is in hot water after allegedly making false claims about its cancer vaccine, Anktiva, leading to a securities fraud class action. The FDA called out the company for saying Anktiva can cure and prevent all cancer, causing a big drop in their stock price. Investors who bought ImmunityBio shares between January 19 and March 24, 2026, have until May 26, 2026, to file for lead plaintiff status in the lawsuit. What does it mean for you? If you invested in ImmunityBio during this time and lost money, you might want to consider joining the lawsuit to potentially recover your losses. You have until May 26, 2026, to make your move.

Original source Read the full story →
▲ 1,724 voters this week
How we select stories →
More from this briefing
Costa Rica Courts European Investors for Growth → Powder Coatings Market Surging to $23 Billion by 2031 → Lazard CEO to Speak at Financials Conference → ECB Innovates Payments, Explores AI for Stability → ECB Unveils Financial Stability Updates for Eurozone → ECB Revamps Policies for Eurozone Stability → ECB Unveils Major Updates for Eurozone Finance → ECB Updates: Payment Pricing, Climate Reports, Stability Boost → Costa Rica Targets European Investment in Innovation → Costa Rica Courts Global Investors for Growth → Caris Life Sciences Unveils 32 Groundbreaking Cancer Studies → Trace Systems Lands $1.81B Military Tech Contract → ESENTIA Debuts Strong with $2 Billion Bond Sale → Shanghai Electric Boosts Green Energy Initiatives → Caliway Advances Fat-Reducing Drug with Global Study → KOIN 6 Expands Spotlight to All School Activities → Mount Fako Lahar Floods Disrupt Buea Life → Shorter Hospital Stays Impact Sterilization Rates → Join the Fight to Eradicate Leprosy Now → ZTE Leads in Sustainability with Bold Achievements → US-Sweden Boost Defense, Tech Collaboration →

Get stories like this every morning.

Five-minute intelligence briefing — in your inbox at 6 AM.

Subscribe now →